美国退伍军人类风湿关节炎患者中甲氨蝶呤后升级生物制剂的城市与农村地区差异
这项回顾性队列研究利用美国退伍军人事务部全国数据库,纳入2005至2014年间首次处方甲氨蝶呤的17395例类风湿关节炎退伍军人,其中42%居住在农村。随访至2016年,19%在两年内启动生物制剂。多变量模型显示城市居住与生物制剂启动风险较高相关(校正HR 1.10,95%CI 1.02-1.18)。
要点
- 城市居住的退伍军人RA患者启动生物制剂的风险较农村居住者略高(校正HR 1.10)。
- 17395例患者中19%在甲氨蝶呤开始后两年内启动生物制剂。
- 在VA医疗系统内,城乡差异幅度不大,提示差异不易仅由农村性解释。
核心结论
- 在VA医疗系统的类风湿关节炎退伍军人中,农村与城市居住者启动生物制剂的差异仅为中等程度。
- 这些发现提示,在VA医疗系统内,差异不易由农村性来解释。
研究设计与样本
- 回顾性队列研究,使用美国退伍军人事务部全国数据库。
- 纳入2005年至2014年间首次处方甲氨蝶呤的成年类风湿关节炎患者,随访数据至2016年。
- 城乡状态按退伍军人健康管理局的城市/农村分类划分。
- 主要结局为甲氨蝶呤开始后两年内启动生物制剂的时间。
- 采用多变量Cox比例风险模型,校正人口学特征、合并症及类风湿因子或抗环瓜氨酸肽抗体阳性。
主要发现
- 共纳入17395例符合标准的退伍军人,88%为男性,42%居住在农村。
- 3259例(19%)在随访前两年内启动生物制剂。
- 多变量模型中,城市居住与农村居住相比,生物制剂启动风险较高且具统计学显著性(校正HR 1.10,95%CI 1.02-1.18)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Racial and ethnic disparities in rheumatoid arthritis (RA) outcomes are well recognized. However, whether disparities in RA treatment selection and outcomes differ by urban versus rural residence, independent of race, have not been studied. Our objective was to evaluate whether biologic disease-modifying antirheumatic drug (bDMARD) initiation after methotrexate administration differs by rural versus urban residence among veterans with RA. METHODS: In this retrospective cohort study using national US Veterans Affairs (VA) databases, we identified adult patients with RA based on the presence of diagnostic codes and DMARD administration. We included patients receiving an initial prescription of methotrexate (index date) between 2005 and 2014, with data through 2016 used for follow-up. Urban-rural status was categorized using the Veteran Health Administration's Urban/Rural classification. Our primary outcome of interest was time to biologic initiation within two years of starting methotrexate. Multivariable Cox proportional hazards models were conducted adjusting for demographics, comorbidities, and rheumatoid factor or anti-cyclic citrullinated peptide positivity. RESULTS: Among 17,395 veterans with RA (88% male, 42% with rural residence) fulfilling eligibility criteria, 3,259 (19%) initiated a biologic within the first two years of follow-up. In multivariable models, residence in an urban area was associated with a statistically significant higher biologic administration compared to rural areas (adjusted hazard ratio 1.10 [95% confidence interval 1.02-1.18]). CONCLUSION: Our study found only modest differences in the initiation of biologic therapies among rural- versus urban-residing veterans with RA in the VA health care system. These findings suggest that disparities are not easily explained by rurality within the VA health care system.
引用
- Naik A, Baraff A, Wysham KD, et al. Escalation to Biologics After Methotrexate Among US Veterans With Rheumatoid Arthritis Grouped by Rural Versus Urban Areas. Arthritis Care Res (Hoboken). 2024. PMID: 39467025. doi:10.1002/acr.25457
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。